Oral Contraceptive Use and Ovarian Cancer Risk Among Carriers of BRCA1 or BRCA2 Mutations

British Journal of Cancer - United Kingdom
doi 10.1038/sj.bjc.6602239
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2008English

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

JAMA - Journal of the American Medical Association
Medicine
2010English

Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers

Clinical Cancer Research
Cancer ResearchOncology
2004English

Intron Variants of the P53 Gene Are Associated With Increased Risk for Ovarian Cancer but Not in Carriers of BRCA1 or BRCA2 Germline Mutations

British Journal of Cancer
Cancer ResearchOncology
1999English

Timing of Births and Oral Contraceptive Use Influences Ovarian Cancer Risk

International Journal of Cancer
Cancer ResearchOncology
2017English

Plasma Osteoprotegerin and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Oncotarget
Oncology
2016English

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer

Cancers
Cancer ResearchOncology
2018English

Contralateral Mastectomy and Survival After Breast Cancer in Carriers of BRCA1 and BRCA2 Mutations: Retrospective Analysis

British Medical Journal
Medicine
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy